Second guilty plea in trade secrets conspiracy to steal cancer research from GlaxoSmithKline and sell it in China
Tao Li admitted to one felony count in the theft case.
A second scientist pleaded guilty Friday to taking part in a conspiracy to steal trade secrets — in the form of cancer drug research — from the pharmaceutical giant GlaxoSmithKline. Tao Li admitted to one felony count in a federal indictment that alleged he received proprietary information from a biochemist inside GSK, and set up a company called Renopharma to market and sell the science in China. Li faces up to 10 years in prison, and his sentencing is scheduled for Jan. 4. Defendant Yu Xue, who worked at GSK's Upper Merion lab, entered a guilty plea in the case last month.
Jay L. Zagorsky, The Conversation
Reggie Ugwu, New York Times
Michelle Chapman, Associated Press
Damian J. Troise and Alex Veiga, Associated Press
Emily Steel, Kalley Huang, Ryan Mac, and Tripp Mickle, New York Times
Olivia Raimonde, Bloomberg
Julia Carpenter, Washington Post
Miriam Waldvogel, Washington Post
Bernard Condon and Barbara Ortutay, Associated Press
Review
Scott Nover, Danielle Paquette, and Brianna Sacks, Washington Post
Steve Thompson, Washington Post
Dee-Ann Durbin, Associated Press
Josh Boak and Michelle L. Price, Associated Press
Dylan Johnson
Hannah Chang

























